Olaparib and Rucaparib in the Maintenance Setting for Ovarian Cancer

Don Dizon, MD of Massachusetts General Hospital discusses the use of novel agents in ovarian cancer. He states that Olaparib and Rucaparib are not FDA approved for clinical trials but are approved for... Author: SGO2017 Added: 03/21/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts